Melbourne, Australia and Madison, WI USA, 6 July 2023: INOVIQ Limited (ASX:IIQ) (INOVIQ), an innovative developer of exosome solutions and precision diagnostics, and Promega Corporation (Promega), a global leader in innovative technologies, tools and?technical support?to the life sciences industry, today announced a joint marketing agreement to co-market INOVIQ’s EXO-NET® exosome capture technology and Promega Nucleic Acid purification systems worldwide.
Joint marketing agreement
INOVIQ and Promega have formalized a global joint marketing agreement that will offer world-class exosome solutions for manual and high-throughput exosome isolation and nucleic acid extraction to researchers and industry for exosome-based biomarker discovery and diagnostics development.
For more information, download the attached PDF.
Download this document
